Clinical trial
Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1…
NCT00131677 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00131677 |
|---|---|
| Title | Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men |
| Official title | Phase II Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | San Francisco Department of Public Health AIDS Research Consortium of Atlanta |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infection |
| Intervention type | Drug |
| Interventions | tenofovir disoproxil fumarate, placebo |
| Enrollment | 400 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Aug 19, 2005 |
| Last update posted | Mar 10, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: